MANILA, Philippines — Local government units (LGUs) that rolled out e-Governance efforts involving fully?automated business permits and licensing systems (BPLS) collected more revenue. But thin ...

Anyone can code using AI. But it might come with a hidden cost. Subscribe to read this story ad-free Get unlimited access to ad-free articles and exclusive content. Over the past year, AI systems have ...

Companies are scrambling to deal with the glut. Credit...Mojo Wang Supported by By Mike Isaac and Erin Griffith Reporting from San Francisco When a financial services company recently began using ...

The unveiling of a Texas Historical Marker at Fort Worth’s Veterans Memorial Park to honor the first Native American code talkers to serve in the U.S. military, on Wednesday, April 1, 2026. From left, ...

The Java ecosystem has historically been blessed with great IDEs to work with, including NetBeans, Eclipse and IntelliJ from JetBrains. However, in recent years Microsoft's Visual Studio Code editor ...

Fortnite will finally allow creators to make their own officially-licensed Star Wars minigames, beginning this week. The ability to create Star Wars-themed games within Fortnite has long been promised ...

Fans were gripping fences all Sunday morning as the sounds of racecars serenaded the tens of thousands who flocked to IndyCar’s inaugural Java House Grand Prix of Arlington. Kyle Kirkwood won the race ...

With Claude enjoying a moment of newfound popularity among regular people, Anthropic is previewing an update designed to make its chatbot better at explaining some concepts. Starting today, Claude can ...

Despite wide availability of biologic drugs for asthma, use of these injectable medicines remains low — patients just dislike frequent injections. Generate Biomedicine’s lead drug candidate could ...

TECHKON announced today that its color QA management suite ChromaQA now can generate accurate spectral data for color standards only defined in CIELab values DANVERS ...

Feb 23 (Reuters) - Drug developer Generate Biomedicines said on Monday it was targeting a valuation of up to $2.17 billion in its U.S. initial public offering, tapping into a resurgent biotech market ...

Generate Biomedicines Inc., a biotechnology firm using artificial intelligence in drug development, is seeking to raise as much as $425 millon in an initial public offering, as listing activity in the ...